FPSUF (Capha Pharmaceuticals) EPS (Basic): $0.00 (TTM As of Jun. 2025)


What is Capha Pharmaceuticals EPS (Basic)?

Capha Pharmaceuticals FPSUF EPS (Basic) is $0.00 as of Jun. 2025.

Capha Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Jun. 2025 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.

Capha Pharmaceuticals's EPS (Diluted) for the three months ended in Jun. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.

Capha Pharmaceuticals's EPS without NRI for the three months ended in Jun. 2025 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2025 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Capha Pharmaceuticals  (OTCPK:FPSUF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Capha Pharmaceuticals EPS (Basic) Related Terms

Capha Pharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Capha Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capha Pharmaceuticals EPS (Basic) Chart

Capha Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.00 0.00 0.00

Capha Pharmaceuticals Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Capha Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Capha Pharmaceuticals's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.05-0)/64.431
=-0.00

Capha Pharmaceuticals's Basic EPS for the quarter that ended in Jun. 2025 is calculated as

Basic EPS (Q: Jun. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.011-0)/64.431
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $0.00 mean?
Capha Pharmaceuticals (FPSUF) has a EPS (Basic) of $0.00 as of Jun. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Capha Pharmaceuticals and its competitors.
Is Capha Pharmaceuticals' EPS (Basic) too high?
Capha Pharmaceuticals' current EPS (Basic) is $0.00.
How does Capha Pharmaceuticals' EPS (Basic) compare to GRYN and TAUG?
Capha Pharmaceuticals' EPS (Basic) of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Capha Pharmaceuticals and its competitors. Capha Pharmaceuticals's current EPS (Basic) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capha Pharmaceuticals stock overvalued right now?
Capha Pharmaceuticals (FPSUF) has a current EPS (Basic) of $0.00. The current EPS (Basic) is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Capha Pharmaceuticals (FPSUF), the current EPS (Basic) is $0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Capha Pharmaceuticals Business Description

Address 4205 Gellatly Road, Suite 324, West Kelowna, BC, CAN, V4T 2K2
Capha Pharmaceuticals Inc is a Canada-based company principally operating in the pharmaceutical industry. The company produces and distributes products in Canada and the United States of America.